Spotlight On... Google discloses 30 grant winners in disabilities innovation challenge; Cambridge researchers image cancer drug effectiveness; NIH backs Phase II tissue-integrated oxygen sensor study; and more...

Google will award a series of grants of roughly $500,000 to $1.5 million apiece to the 30 nonprofit winners of its Impact Challenge for innovative technology to address the needs of the disabled. They include The Center for Discovery, which received $1.1 million to develop an add-on device to make any wheelchair power-driven; Ezer Mizion and Click2Speak, which got $400,000 to create an on-screen keyboard that can be used without hands; and the ProPortion Foundation, which got $1 million to develop a fully automated device that creates high-quality sockets for prosthetics. More

@FierceMedDev: ICYMI yesterday: Medtronic shut down study of Infuse bone graft and hid the evidence: Report. More | Follow @FierceMedDev

@EmilyWFierce: Incoming Bayer CEO looks to deals to beef up $1.7B animal health unit. FiercePharma article | Follow @EmilyWFierce

> Cambridge, U.K.-based researchers have developed an imaging technique designed to let physicians see if anti-cancer drugs are proving effective within a day or two of starting treatment. More

> Small-cap AtriCure ($ATRC) has received FDA clearance for its CryoForm Cryoablation Probe for use in cardiac arrhythmia surgical ablation procedures. It was launched in Europe in October 2015. More

> Profusa has nabbed a $1.75 million Small Business Innovation Research (SBIR) grant under the National Heart, Lung, and Blood Institute (NHLBI) to support Phase II research for its Lumee tissue-integrated biosensors that continuously monitor oxygen in peripheral artery disease patients. More

Biotech News

@FierceBiotech: ICYMI: Roche/AbbVie team scores 'breakthrough' FDA OK of leukemia drug venetoclax. News | Follow @FierceBiotech

@JohnCFierce: ICYMI: $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for IPO. Report | Follow @JohnCFierce

> Forbion raises $200M for EU and North American biotechs, funds to focus on unmet needs. News

> 4D Pharma acquires Spanish CRO Instituto Biomar, buys into its microbial fermentation service. Story

> London University spin-off hails new tooth repair technology 'while you sleep.' More

Pharma News

@FiercePharma: Obama aides focus on overall pharma benefits in TPP, not biologics data period. More from FiercePharmaAsia | Follow @FiercePharma

@CarlyHFierce: ICYMI from FiercePharmaMarketing: Ironwood exec's brainstorm gives Allergan a marketing edge with Linzess. More | Follow @CarlyHFierce

> Incoming Bayer CEO looks to deals to beef up $1.7B animal health unit. Article

> Merck CEO Frazier scores $24.2M for 2015, earning a spot among pharma's highest-paid. Story

> Does Biogen selling its hemophilia franchise make sense? Leerink's top analyst says yes. More

Pharma Manufacturing News

> $60M Eli Lilly warehouse heist not the fault of security firm, jury says. Article

> Spanish regulators recall Inmunotek vaccines, suspend manufacturing at Madrid facility. Story

> Recipharm closes deal for Indian sterile injectables maker. More

> FDA bans products from 3 more Chinese drugmakers. Item

> J&J gets FDA approval for continuous manufacturing of Prezista. Report

Drug Delivery News

> GE Ventures, Mayo Clinic launch new personalized cell and gene therapy biz. News

> Phase III testing data looks promising for Highland's ADHD drug Benjorna. More

> Two-faced pill releases drugs to GI lining, and its smooth side keeps it stable. Report

> Oasmia reports affirming results in recent trial of XR-17 nanotechnology delivery platform. Story

> IBM to open its first Watson Health European Center of Excellence in Italy. Article

Pharma Asia News

> Genetic tests identify 6 types of liver cancer among Japanese patients. More

> Obama aides focus on overall pharma benefits in TPP, not biologics data period. Story

> Singapore's NMT pumps equity into CAO TCM-derived oncology play. Item

> After raising a $101M IPO, Chi-Med begins first blood cancer trial in Australia. Report

> Korea's CJ HealthCare signs next-gen Nexium pact with China's Shandong Luoxin. Article

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.